Validation of High-Risk Features for Stent-Related Ischemic Events as Endorsed by the 2017 DAPT Guidelines
- 1 May 2019
- journal article
- research article
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 12 (9) , 820-830
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Balancing Long-Term Risks of Ischemic and Bleeding Complications After Percutaneous Coronary Intervention With Drug-Eluting StentsThe American Journal of Cardiology, 2015
- Procedural Outcomes of Chronic Total Occlusion Percutaneous Coronary InterventionJACC: Cardiovascular Interventions, 2015
- 2014 ESC/EACTS Guidelines on myocardial revascularizationEuropean Heart Journal, 2014
- Standardized Bleeding Definitions for Cardiovascular Clinical TrialsCirculation, 2011
- Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)European Heart Journal, 2010
- The Relationship and Threshold of Stent Length With Regard to Risk of Stent Thrombosis After Drug-Eluting Stent ImplantationJACC: Cardiovascular Interventions, 2010
- Myocardial infarction adjudication in contemporary all-comer stent trials: balancing sensitivity and specificityEuroIntervention, 2010
- Predictors of Coronary Stent ThrombosisJACC, 2009
- Clinical End Points in Coronary Stent TrialsCirculation, 2007
- Effects of stent length and lesion length on coronary restenosisThe American Journal of Cardiology, 2004